The NF-KB/Rel family of at least five transcription factor polypeptides is thought to function both as a developmental regulator in B cells and as a rapid response system in all cells. To examine this notion in more detail, we determined the protein contents of both the inducible and constitutive NF-KB/Rel activities in a pre-B-cell line, 70Z/3, and a mature B-cell line, WEHI 231. NF-KB p50/p65 is the major inducible nuclear complex after lipopolysaccharide or phorbol myristate acetate treatment of 70Z/3 cells. (617) 253-2135. Fax: (617) 253-2153. tors. The signal transduction pathways leading to the activation of NF-KB by these stimuli Pre yet to be identified. Approximately 10-bp KB sites for NF-KB have been found in the promoters/enhancers of many cellular and viral genes. These putative target genes of NF-KB, including IgK, cytokines, cytokine receptors, and Myc, are involved in the regulation of the acute-phase response, inflammation, lymphocyte activation, and cell growth or differentiation. Deregulation or mutation of some NF-KB/Rel and IKB family members has been associated with tumorigenesis (14).
B-cell differentiation is an ordered process culminating in expression of rearranged immunoglobulin (Ig) heavy (H)-and light (L)-chain gene products (7) . Pre-B cells express ,u IgH protein in their cytoplasm, while the transition from the pre-B to B stage is accompanied by the rearrangement and expression of the K L-chain gene. Thus, the regulation of IgK gene expression is considered a crucial element in B-cell differentiation. The K L-chain intronic enhancer contains several transcription factor binding sites, including a KB site and three E boxes, that contribute to enhancer activity both in vitro and in vivo (42) . Integrity of the KB site is necessary for any enhancer activity to be manifest: it is bound by the NF-KB protein (24, 41) . Among B-lineage cell lines, the presence of nuclear NF-KB activity correlates with K gene expression (42) . One of the most useful cell lines has been 70Z/3, which contains a functionally rearranged but transcriptionally inactive IgK locus (35) . Stimulation of 70Z/3 cells with the B-cell mitogen lipopolysaccharide (LPS) causes nuclear translocation of NF-KB and concomitant K L-chain transcription, followed by surface expression of an assembled lgM (33) . By analogy, the constitutive NF-KB activity in mature B cells has been thought to play a role in the regulation of IgK gene expression and B-cell differentiation.
NF-KB is actually present in the cytoplasm of most cells as an inactive complex with an inhibitor protein, IKB (3) . From the inactive NF-KB/IKB complex, DNA binding NF-KB can be released by stimulating cells with various exogenous agents (15) . For example, NF-KB is activated in B cells by LPS, phorbol myristate acetate (PMA), or cross-linking of surface IgM. In T cells, NF-KB responds to a variety of activating stimuli, such as PMA, phytohemagglutinin, interleukin-2 (IL-2), and cross-linking of surface CD3, CD28, and T-cell recep-5350 LIOU ET AL.
NF-KB/Rel binding activity. Nuclear KBF-1 (a p50 homodimer) and p52 homodimers have been detected in unstimulated T cells and macrophages by using oligonucleotide probes containing the IL-2 or IL-2 receptor (IL-2R) KB sites to which the homodimers bind especially well (21, 22) . It was recently reported that crude spleen B-cell extracts express p50 and RelB in constitutive complexes (25) .
As a step toward understanding the physiological role of NF-KB in IgK gene regulation, B-cell proliferation, and differentiation, we have characterized the nature and regulation of the constitutive NF-KB activity in B-lineage cells. Our Stimulation conditions for cells were the following: cycloheximide (10 ,ug/ml) added 30 min before the addition of other stimuli; LPS (Sigma L2880; 10 ,ug/ml) for the indicated time; PMA (100 nM) for 4 h; and tumor necrosis factor alpha (TNF-ao; Genzyme; 20 ng/ml) for 2 h. For cross-linking surface
IgM on B cells, goat anti-mouse IgM F(ab')2 (Jackson ImmunoResearch) was added at a concentration of 30 ,ug/ml for 4 h. For phosphopeptide analysis, cells were treated with PMA for 10 min. Purification of resting splenic B cells. Erythrocytes were removed from single-cell splenocyte populations by ammonium chloride lysis. Crude spleen extracts were prepared from these cells. Resting B cells were purified from these crude spleen populations by one round of complement lysis with a Thy 1.2 antibody to remove T cells. The remaining cells were then fractionated through Percoll gradients (8) to isolate small resting B cells, contained between 66 and 70% Percoll. These cells were collected, washed extensively, and incubated in medium for stimulation with anti-IgM or LPS.
Electrophoretic mobility shift assay (EMSA) and antibody inhibition. The nuclear and cytosolic fractionation procedure was slightly modified from the basic protocol of Dignam et al. (9) . Cells were harvested, washed once with phosphate-buffered saline and resuspended into buffer A (10 mM N-2-hydroxyethylpiperazine-N'-2-sulfonic acid [HEPES; pH 7.9], 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol) plus 0.1% Nonidet P-40 (NP-40). Cells were lysed on ice for 2 min and checked for complete lysis under a microscope. Nuclei were spun down, and the supernatant was saved as the cytosolic fraction. The nuclear pellet was resuspended in buffer C (20 mM HEPES [pH 7.9], 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol), sonicated for a few seconds to decrease viscosity, and rotated in the cold room for 30 min. Ultracentrifugation was performed to remove insoluble debris. The supernatant was nuclear extract.
The EMSA was performed as described previously (41) . For antibody inhibition experiments, antibody was purified by ammonium sulfate precipitation of crude immune serum. The optimal amount of antibody used in EMSA inhibitions was determined by using purified proteins. For a 20-,u DNA binding reaction, 5 ,ug of purified antibody was added per reaction. Antibody was incubated with a mixture of nuclear extract and poly (dI-dC) in iX DNA binding buffer (41) on ice for 30 min before the addition of 32P-labeled KB probe. The reaction was continued for 15 min at room temperature, and the mixture was loaded onto a 5% native polyacrylamide gel. For high-resolution electrophoresis, gels were prerun at 160 V for 2.5 h, continuing for 3 to 3.5 h after the samples were loaded.
Immunoprecipitation and pulse-chase experiments. Cells were harvested, washed, and incubated in RPMI medium without either methionine or phosphate for 40 min prior to labeling for 2 h in the presence of 0.5 to 2 mCi of [35] The nuclear NF-KB/Rel complexes were then tested for their susceptibility to inhibition by IKB-a. For this purpose, IKB-a was purified as a fusion protein with glutathione S-transferase (27) . The inducible nuclear complex in 70Z/3 cells and the constitutive complex in WEHI 231 cells were equally sensitive to inhibition by IKB-a-glutathione S-transferase (data not shown). Thus, there is no major qualitative difference in the sensitivity to lKB-a inhibition between the constitutive and the inducible nuclear NF-KB/Rel complexes in these two cell types.
Most cellular NF-KB/Rel in unactivated cells is stored in the cytoplasm as a non-DNA-binding complex with IKB or an IKB-containing precursor molecule like p105 (19, 36, 37 From several gels probed with antibody specific to NF-KB and IKB proteins, it was evident that WEHI 231 cells had 3-to 10-fold-higher levels of p50, Rel, IKB-a, Bcl-3, and p105 than did 70Z/3 cells (Fig. 3) . p65 protein was twofold less in WEHI 231 than in 70Z/3 cells (Fig. 3B ). There was a continuous degradation (and therefore resynthesis) of p65, Rel, IKB-a, and p105 in WEHI 231 cells because a 4-h cycloheximide treatment reduced the levels of these proteins (Fig. 3B, C, D , and G). About 30% of total cellular p5O and 20% of the Rel proteins was in the nuclear extract of uninduced WEHI 231 cells, but none was found in 70Z/3 nuclei (Fig. 3A and C) . The nuclear p50 and Rel made up the preponderance of the constitutive NF-KB/Rel activity, as detected by EMSA in WEHI 231 nuclei (Fig. 1A) . Upon induction, 50 to 60% of total p5O and Rel proteins were found in WEHI 231 nuclei ( Fig. 3A and C) , demonstrating induced translocation of these proteins. The same stimuli also caused nuclear translocation of 30 to 40% of total p5O and 35 to 55% of p65 protein in 70Z/3 cells (Fig. 3A and B) .
With respect to the NF-KB-bound proteins, there was a discernible level of IKB-a in WEHI 231 cells but little in 70Z/3 cells (Fig. 3D) . Thus, the constitutive nuclear NF-KB/Rel activity in WEHI 231 cells could not be attributed to reduced IKB-a expression. Bcl-3 in WEHI 231 cells was sevenfold higher in the cytosol than in the nuclei (Fig. 3E ), and induction with LPS and PMA caused little or no increase in the nuclear concentration. 70Z/3 cells did not have detectable Bcl-3. IKB--y and p105 were present exclusively in the cytosolic fraction ( Fig.  3F and G) . The level of IKB--y was slightly higher in 70Z/3 cells than in WEHI 231 cells, consistent with the higher expression level of IKB--y mRNA in 70Z/3 cells (20, 26) . Interestingly, LPS but not PMA treatment of both 70Z/3 and WEHI 231 cells led to loss of the p105 precursor (Fig. 3G) .
To characterize the kinetics of p105 processing, WEHI 231 cells were induced at various time periods by either LPS or PMA. Equal amounts of lysate were resolved by SDS-polyacrylamide gel electrophoresis and subjected to Western blot analysis using anti-p5O antibody. LPS induction causes increased processing of p105, whereas PMA did not (Fig. 3H) . The induced processing became obvious after 1 h of LPS treatment (decreased 45%) and further enhanced after 4 h of stimulation (decreased 65%). Other stimuli, such as anti-IgM and TNF-a, like PMA, did not cause p105 processing in WEHI 231 cells (data not shown). These results suggest that various stimuli trigger different regulatory pathways for the activation of NF-KB/Rel protein.
IKB-a protein turns over rapidly in WEHI 231 cells. IKB-a is rapidly degraded following stimulation with a variety of agents (5, 18) . Free IKB-at is degraded within about 30 min, whereas it is stable for longer than 6 h when complexed with p65 (40) . Since there is continuous synthesis of IKB-a in WEHI 231 cells (Fig. 3D) , there must be a continuous turnover maintaining a dynamic balance of IKB-a in these cells. To test this interpretation, we measured the turnover of IKB-a in both 70Z/3 and WEHI 231 cells by pulse-chase experiments (Fig. 4) .
Cells were labeled with [35S]methionine for 2 h and chased with cold medium for various times. Lysates were immunoprecipitated with anti-IKB-a antibody, and the 35S-labeled protein bands corresponding to IKB-a from each time point were quantitated. IKB-ao in WEHI 231 cells had a much faster and more extensive degradation than in 70Z/3 cells (Fig. 4) . The fast turnover of IKB-a protein may be partly responsible for the constitutive nuclear pSO/Rel and p5O/p65 in WEHI 231 cells.
Modification by phosphorylation has been suggested as one of the regulatory mechanisms of NF-KB activation in vitro (12) . We therefore tested if phosphorylation of endogenous NF-KB/ Rel or IKB proteins in 70Z/3 and WEHI 231 cells might account for the constitutive nuclear NF-KB/Rel activity in WEHI 231 cells. Results from phosphopeptide analyses indicated that both the basal and inducible phosphorylation patterns of p65, Rel, and IKB-ao were comparable in these two cells (data not shown). Therefore, the constitutive nuclear F F . F . ----. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . We first examined whether these cell lines express constitutive NF-KB activity. The constitutive low-level NF-KB/Rel complexes in nuclei from uninduced B-cell lines were three-to fivefold higher than in 3T3 fibroblasts (Fig. SA) . Most mature B-cell lines and plasmacytomas tested contained constitutive NF-KB/Rel complexes in their nuclear fractions (data not shown). LPS or PMA stimulation of B-cell lines and splenic B cells increased the nuclear level of NF-KB/Rel complexes (Fig.  5A ). The composition of each complex was analyzed by inhibition with specific antibody, using higher-resolution EMSA. The complexes in two mature B cells, XAg and M12, were inhibited or supershifted by antibody for p50, p65, and Rel (Fig. SB) , suggesting that they consist of pSO/p65, pSO/Rel, or p65/Rel complexes.
When plasmacytomas S194, S107, and J558L were analyzed by EMSA, the complex pattern was very different from that of pre-B-or mature B-cell lines described above. Nuclear extracts of untreated (data not shown) or LPS-induced S107 and J558L revealed four complexes: complex I, composed of p50, p52, and RelB; complex II, consisting of p52 and Rel; complex III, with p50, p65, and Rel; and complex IV, a p50 homodimer (Fig. 5C ). LPS-induced S194 had a unique pattern in which complex V was p50 and p65, complex VI only showed RelB, and complex IV was P502 (Fig. 5C) . Therefore, all plasmacytomas expressed RelB-containing complexes either constitutively or upon induction. Two of the three plasmacytomas tested also expressed p52-containing complexes. p52 and RelB may thus be expressed at the latest stage of B-cell differentiation, in contrast to p50, p65, and Rel, which are expressed at an intermediate stage, and p50 and p65, which predominate in the pre-B-cell stage.
LPS is a potent B-cell mitogen capable over days of promoting B-cell differentiation in vitro. To test whether expression of p52 and RelB proteins would be induced, we analyzed nuclear extracts obtained from 70Z/3 pre-B-and M12 B-cell lines that were treated with LPS for 3 days. LPS treatment caused the cells to differentiate into lymphoblasts with a dramatic increase in cell volume. The binding pattern of their nuclear extracts consisted of the same four complexes found in plasmacytomas ( Fig. SC and D (Fig. SA) . LPS, PMA, and anti-IgM were capable of further inducing nuclear translocation of NF-KB/Rel complexes in resting splenic B cells (Fig. 5A and data not shown) . Nuclear extracts prepared from two batches of splenic B cells treated with anti-IgM were analyzed by antibody treatment and EMSA (Fig. 5E) (10) . In particular, the pSO/p65 heterodimer was the best transcriptional activator of the canonical Ig KB site (Fig. 6 ). Both p50 and p65 contribute in the transactivation of the Ig KB site because neither homodimer was as good as the heterodimer, although p65 was quite effective on its own. In contrast, all complexes, except the p50 homodimer, failed to transactivate through the IL-2R KB site (Fig. 6) . The transcriptional activity of p50 on the IL-2R KB site was comparable to its activity on the IgK and IFN-, sites. Intriguingly, p65 homodimer strongly activated transcription through both the IFN-P and Myc KB sites but not the IL-2R site. Rel synergized with p65 in the activation of the IFN-, KB site. Overall, Rel itself was a weak transcription activator on the selected KB sites studied. The optimal KB sites for Rel are yet to be identified. The results suggest that various assessed by antibody inhibition as described for Fig. 1A . Percentage of residual binding was quantitated by a PhosphoImager. (C) S194, S107, and J558L plasmacytoma cells contain additional p52 and RelB complexes. Shown is an EMSA of nuclear extracts from S194, S107, and J558L plasmacytoma cells treated with PMlA for 4 h. The S107 line used in this study is a different subline from that described by Atchison NF-KB/Rel components can regulate distinct sets of target genes during B-cell activation, although the particular responses seen in this experiment were a consequence both of the products of the transfected genes and of endogenous complexes that they may induce.
DISCUSSION
Originally, NF-KB was defined as an activity that shifted the mobility of a DNA probe containing a KB site. Later, the subunit composition of latent NF-KB in unactivated cells was found to be p50 and p65. (10) . This is due to a conformational change in p5O when binding to the MHC class I site. p52/p65 had the capacity to bind to various KB sites, but it failed to activate reporter constructs with either H2 or IL-2R KB sites (6, 34, 39 a lower level of IKB-y protein than 70Z/3 cells do. The 2.6-kb spliced mRNA variant corresponding to IKB--y is expressed at a higher level in pre-B-cell lines than in mature B cells (12, 27) . Such a differentiation-mediated down-regulation of the IKB--y mRNA may be relevant to the nuclear translocation of p5O homodimer. In addition, the high expression of Bcl-3 protein in WEHI 231 cells may facilitate nuclear transport of p5O; Bcl-3 as a coactivator of p5O may in turn enhance the transcription of target genes through its interaction with p5O (11).
